Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Language
Year range
1.
China Pharmacy ; (12): 1060-1065, 2023.
Article in Chinese | WPRIM | ID: wpr-972947

ABSTRACT

OBJECTIVE To study the effects and potential mechanism of wogonin (Wog) on airway inflammation in rats with chronic obstructive pulmonary disease (COPD). METHODS Eighty-four rats were randomly divided into control group, model group, Wog low-dose and high-dose groups (intragastric administration of 50, 100 mg/kg), aminophylline group (positive control, intragastric administration of 2.3 mg/kg), recombinant rat receptor-interacting protein kinase 1 [rRIPK1, receptor-interacting protein kinase 1 (RIPK1) activator] group (tail vein injection of 8 µg/kg), and Wog high-dose+rRIPK1 group (intragastric administration of Wog 100 mg/kg+tail vein injection of rRIPK 8 µg/kg), with 12 rats in each group. Except for control group, COPD model of other groups was induced by smoking combined with tracheal injection of lipopolysaccharide. Twenty-four hours after successful modeling, the rats were administered once a day for 4 weeks. The changes of peak inspiratory flow (PIF), peak expiratory flow (PEF) and minute ventilation (MV),forced expiratory volume in one second(FEV1)/forced vital capacity(FVC) were measured after the last medication; the serum levels of interleukin 1β(IL-1β), IL-6 and tumor necrosis factor-α (TNF-α) were measured by ELISA; the pathological changes of lung tissue in rats were observed; the apoptotic rate of pulmonary epithelial cells was detected. mRNA expressions of RIPK1, RIPK3 and mixed lineage kinase domain-like protein (MLKL), and protein expressions of RIPK1, RIPK3 and p-MLKL were all detected in lung tissue of rats. RESULTS Compared with control group, PIF, PEF, MV and FEV1/FVC of model group were decreased significantly (P<0.05), while the levels of IL-1β, IL-6 and TNF- α were increased significantly (P<0.05); there was a large number of inflammatory cells infiltration in the lung tissue and bronchialwall thickening in model group; the apoptotic rate of pulmonary epithelial cells,mRNA expressions of RIPK1, RIPK3 and MLKL, protein expressions of RIPK1, RIPK3 and p-MLKL were increased significantly (P<0.05). Compared with model group, above indexes of rats were improved significantly in Wog low-dose and high-dose groups (P<0.05), and pathological injuries were alleviated significantly. The corresponding indexes of rats were worsened in rRIPK1 group (P<0.05), and pathological damage had further worsened. rRIPK1 significantly attenuated the inhibitory effect of high-dose Wog on airway inflammation and RIPK1/RIPK3/ MLKL pathway in COPD rats (P<0.05). CONCLUSIONS Wog may improve airway inflammation in COPD rats by inhibiting RIPK1/RIPK3/MLKL signal pathway.

SELECTION OF CITATIONS
SEARCH DETAIL